drugset / Trial / NCT00188942

A Neuroimaging Investigation of Brain Activity in Major Depressive Disorder and Bipolar Disorder

NCT00188942

Non-randomizedSingle-groupOpen-labelDiagnostic

Summary

This study employs functional magnetic resonance imaging to compare brain activation patterns during a depressive episode in patients diagnosed with bipolar disorder, major depressive disorder, and a group of healthy control subjects. Depressed patients will be treated with a combination of fluoxetine and olanzapine and undergo MRI scans before, during, and after pharmacotherapy.

Timeline

Start
2005-02
Primary completion
2009-06
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fluoxetine Small molecule
Comparator Olanzapine Small molecule